← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA2010.5x17.3x28.1x
EV / LTM revenue341.3x1.8x3.9x
Premium to unaffected price4721%30%55%
Premium to 30-day VWAP1128%40%53%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
0901802009: 15 deals, 2 clean on every measure2009152010: 159 deals, 30 clean on every measure20101592011: 151 deals, 70 clean on every measure20111512012: 148 deals, 93 clean on every measure20121482013: 144 deals, 92 clean on every measure20131442014: 148 deals, 59 clean on every measure20141482015: 161 deals, 81 clean on every measure20151612016: 180 deals, 103 clean on every measure20161802017: 161 deals, 90 clean on every measure20171612018: 176 deals, 93 clean on every measure20181762019: 171 deals, 90 clean on every measure20191712020: 101 deals, 44 clean on every measure20201012021: 172 deals, 85 clean on every measure20211722022: 127 deals, 77 clean on every measure20221272023: 121 deals, 62 clean on every measure20231212024: 125 deals, 82 clean on every measure20241252025: 159 deals, 84 clean on every measure20251592026: 80 deals, 41 clean on every measure202680
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Healthcare: 11.6x median across 5 dealsHealthcare11.6xn=5
Deals by sector
Healthcare: 22 dealsHealthcare22Financials: 9 dealsFinancials9Real Estate: 9 dealsReal Estate9Technology: 9 dealsTechnology9Other: 7 dealsOther7Industrials: 6 dealsIndustrials6Media & Telecom: 5 dealsMedia & Telecom5Business Services: 4 dealsBusiness Services4Consumer & Retail: 4 dealsConsumer & Retail4Materials: 2 dealsMaterials2Utilities: 2 dealsUtilities2Energy: 1 dealsEnergy1
Deals by buyer type
Financial sponsor: 0 dealsFinancial sponsor0Strategic: 50 dealsStrategic50Management / founder: 0 dealsManagement / founder0Controlling holder: 0 dealsControlling holder0Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 30 dealsUnclassified30
Deals by enterprise value
Under $250m: 19 dealsUnder $250m19$250m to $1bn: 19 deals$250m to $1bn19$1bn to $5bn: 19 deals$1bn to $5bn19$5bn to $20bn: 20 deals$5bn to $20bn20Over $20bn: 3 dealsOver $20bn3Not computed: 0 dealsNot computed0
Deals by industry code
Chemicals, Pharmaceuticals & Allied Products: 15 dealsChemicals, Pharmaceutic…15Business Services & Software: 9 dealsBusiness Services & Sof…9Depository Institutions: 7 dealsDepository Institutions7Holding & Other Investment Offices: 7 dealsHolding & Other Investm…7Instruments, Medical Devices & Optical Goods: 6 dealsInstruments, Medical De…6Communications: 5 dealsCommunications5Building Construction: 4 dealsBuilding Construction4Electronics & Electrical Equipment: 4 dealsElectronics & Electrica…4Health Services: 3 dealsHealth Services3Food & Kindred Products: 2 dealsFood & Kindred Products2
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
First Seacoast Bancorp, Inc.
2026-05-04 · Public merger · $17.25 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Cambridge Savings Bank
Strategic
Financials$81mn.a.n.a.
n.a.
DEFM14A
All cash
Modiv Industrial, Inc.
2026-05-03 · Public merger · $25.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Modiv Operating Partnership, LP
Strategic
Real Estate$527m17.4x11.4x
n.a.
DEFM14A
Includes stock
Global Business Travel Group, Inc.
2026-05-02 · Public merger · $9.50 a share
Gaia Purchaser, Inc.
Unclassified
Industrials$6.1bn20.9x2.1x
60%
DEFM14A
All cash
Esperion Therapeutics, Inc.
2026-05-01 · Public merger · $3.16 a share
Essence Parent Inc.
Unclassified
Healthcare$657m8.7x1.6x
58%
DEFM14A
All cash
XOMA Royalty Corp
2026-04-27 · Public merger · $39.00 a share
HoldCo becoming the holding company of XOMA Royalty
Unclassified
Healthcare$482mn.a.9.9x
29%
DEFM14A
All cash
Organon & Co.
2026-04-26 · Public merger · $14.00 a share
Sun Pharmaceutical Holdings USA, Inc.
Strategic
Healthcare$11bnn.a.1.8x
103%
120% to VWAP
DEFM14A
All cash
RE/MAX Holdings, Inc.
2026-04-26 · Public merger · $13.80 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Rome Wildlife, Inc.
Strategic
Real Estate$795m13.5x2.8x
110%
DEFM14A
Includes stock
TruBridge, Inc.
2026-04-23 · Public merger · $26.25 a share
Inventurus Knowledge Solutions, Inc.
Strategic
Technology$520m30.9x1.5x
88%
DEFM14A
All cash
Webster Financial Corp
2026-04-23 (filed) · Public merger · $48.75 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Not named in the filing
Unclassified
Financials$5.8bn3.8x24.0x
9%
DEFM14A
Includes stock
Electro Sensors Inc
2026-04-20 · Public merger · $7.75 a share
Inc.
Strategic
Industrials$17mn.a.1.6x
75%
DEFM14A
All cash
Sila Realty Trust, Inc.
2026-04-19 · Public merger · $30.38 a share
Sunshine Ultimate Parent LLC
Unclassified
Real Estate$1.6bnn.a.8.2x
19%
26% to VWAP
DEFM14A
All cash
QXO Insulation, LLC
2026-04-18 · Public merger · $505.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Titanium MergerCo, Inc.
Strategic
Other$17bn17.1x3.0x
23%
DEFM14A
Includes stock
Galera Therapeutics, Inc.
2026-04-14 · Public merger · $1.75 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Obsidian Therapeutics, Inc.
Strategic
Healthcare$127mn.a.n.a.
n.a.
DEFM14C
Includes stock
Globalstar, Inc.
2026-04-13 · Public merger · $90.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; EV / LTM EBITDA 106.8x outside 1x to 75x
Amazon.com, Inc.
Strategic
Media & Telecom$11bn106.8x40.6x
n.a.
DEFM14C
Includes stock
Avanos Medical, Inc.
2026-04-13 · Public merger · $25.00 a share
A-AV Holdco I, Inc.
Unclassified
Healthcare$1.2bnn.a.1.7x
n.a.
DEFM14A
All cash
Whitestone REIT
2026-04-08 · Public merger · $19.00 a share
AREG Wizard Parent LP
Unclassified
Real Estate$1.6bnn.a.9.9x
12%
DEFM14A
All cash
Affinity Bancshares, Inc.
2026-03-30 · Public merger · $23.00 a share
Affinity Bank
Strategic
Financials$86mn.a.n.a.
n.a.
DEFM14A
All cash
Two Harbors Investment Corp.
2026-03-27 · Public merger · $10.80 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
CrossCountry Intermediate Holdco, LLC
Unclassified
Real Estate$8.8bnn.a.n.a.
13%
DEFM14A
Includes stock
Olaplex Holdings, Inc.
2026-03-26 · Public merger · $2.06 a share
Held out of the multiples: EV / LTM EBITDA 193.5x outside 1x to 75x
Henkel US Operations Corporation
Strategic
Materials$1.4bn193.5x3.3x
57%
44% to VWAP
DEFM14C
All cash
SunOpta Inc.
2026-03-18 (filed) · Public merger · $6.50 a share
Not named in the filing
Unclassified
Consumer & Retail$1.0bn12.9x1.3x
30%
DEFM14A
All cash
Odysseus (Cayman) Ltd
2026-03-16 (filed) · Public merger · $10.00 a share
Not named in the filing
Unclassified
Financials$73mn.a.n.a.
n.a.
DEFM14A
All cash
National Storage Affiliates Trust
2026-03-16 · Public merger · $25.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Nsa Op, LP
Strategic
Real Estate$1.9bnn.a.2.5x
25%
DEFM14A
Includes stock
Unifirst Corp
2026-03-10 · Public merger · $155.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Cintas Corporation
Strategic
Consumer & Retail$393m1.3x0.2x
21%
DEFM14A
Includes stock
Talkspace, Inc.
2026-03-09 · Public merger · $5.25 a share
Held out of the multiples: EV / LTM EBITDA 138.7x outside 1x to 75x
Universal Health Services, Inc.
Strategic
Healthcare$832m138.7x3.6x
10%
DEFM14A
All cash
DyTb, LLC
2026-03-04 · Public merger · $0.30 a share
USA Rare Earth, Inc.
Strategic
Materials$21mn.a.n.a.
n.a.
DEFM14A
All cash

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More